DrugPatentWatch Database Preview
CAMBIA Drug Profile
When do Cambia patents expire, and when can generic versions of Cambia launch?
Cambia is a drug marketed by Assertio and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge.
The generic ingredient in CAMBIA is diclofenac potassium. There are forty-seven drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the diclofenac potassium profile page.
Summary for CAMBIA
| US Patents: | 4 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 38 |
| Clinical Trials: | 3 |
| Patent Applications: | 2,044 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CAMBIA |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for CAMBIA |
| DailyMed Link: | CAMBIA at DailyMed |
Pharmacology for CAMBIA
| Ingredient-type | Nonsteroidal Anti-inflammatory Compounds |
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
| Physiological Effect | Decreased Prostaglandin Production |
Synonyms for CAMBIA
| 15307-81-0 |
| 15307-86-5 (Parent) |
| 2-((2,6-dichlorophenyl)amino)benzeneacetic acid, monopotassium salt |
| AB0013318 |
| AC-18735 |
| AK163133 |
| AKOS015889752 |
| AKOS015994733 |
| AN-8291 |
| Benzeneacetic acid, 2-((2,6-dichlorophenyl)amino)-, monopotassium salt |
| C14H10Cl2KNO2 |
| C14H10Cl2NO2.K |
| Cambia (TN) |
| Cataflam |
| Cataflam (TN) |
| CGP 45840B |
| CGP-45840B |
| CHEBI:4508 |
| CHEMBL1200804 |
| D00903 |
| Diclofenac potassium |
| Diclofenac potassium (USAN) |
| Diclofenac potassium [USAN:USP] |
| Diclofenac potassium [USAN] |
| Diclofenic potassium |
| DR001603 |
| DTXSID30165212 |
| FT-0603076 |
| H866 |
| HMS3656D18 |
| I01-3215 |
| KS-5037 |
| KXZOIWWTXOCYKR-UHFFFAOYSA-M |
| L4D5UA6CB4 |
| LS-173441 |
| MolPort-005-937-655 |
| Potassium (o-(2,6-dichloroanilino)phenyl)acetate |
| potassium {2-[(2,6-dichlorophenyl)amino]phenyl}acetate |
| potassium 2-(2-((2,6-dichlorophenyl)amino)phenyl)acetate |
| potassium 2-[2-(2,6-dichloroanilino)phenyl]acetate |
| potassium;2-[2-(2,6-dichloroanilino)phenyl]acetate |
| PubChem5895 |
| s3062 |
| SC-01315 |
| SCHEMBL40784 |
| ST51051764 |
| UNII-L4D5UA6CB4 |
| Voltfast |
| Zipsor |
| Zipsor (TN) |
US Patents and Regulatory Information for CAMBIA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assertio | CAMBIA | diclofenac potassium | FOR SOLUTION;ORAL | 022165-001 | Jun 17, 2009 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | |
| Assertio | CAMBIA | diclofenac potassium | FOR SOLUTION;ORAL | 022165-001 | Jun 17, 2009 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||
| Assertio | CAMBIA | diclofenac potassium | FOR SOLUTION;ORAL | 022165-001 | Jun 17, 2009 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | |
| Assertio | CAMBIA | diclofenac potassium | FOR SOLUTION;ORAL | 022165-001 | Jun 17, 2009 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for CAMBIA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Assertio | CAMBIA | diclofenac potassium | FOR SOLUTION;ORAL | 022165-001 | Jun 17, 2009 | ➤ Sign Up | ➤ Sign Up |
| Assertio | CAMBIA | diclofenac potassium | FOR SOLUTION;ORAL | 022165-001 | Jun 17, 2009 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for CAMBIA
| Drugname | Dosage | Strength | RLD | Date |
|---|---|---|---|---|
| ➤ Subscribe | Potassium Oral Solution (Sachet) | 50 mg | ➤ Subscribe | ➤ Sign Up |
International Patents for CAMBIA
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Australia | 2006257072 | ➤ Sign Up |
| New Zealand | 564002 | ➤ Sign Up |
| European Patent Office | 3103441 | ➤ Sign Up |
| Russian Federation | 2008101784 | ➤ Sign Up |
| Guatemala | 200600261 | ➤ Sign Up |
| Poland | 1890680 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
